Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Allogene Therapeutics, Inc. | 929,913 | reported | 02 Feb 2026 | tx 37+28,565,600−12,450,310 |
| Ginkgo Bioworks Holdings, Inc. | 432,900 | reported | 13 Jun 2024 | tx 8+1,534,151−105,263 |
| LAURIER INTERNATIONAL INC | 357,142 | reported | 15 Aug 2016 | tx 67+10,464,225−1,729,163 |
| CAPRICOR THERAPEUTICS, INC. | 80,000 | reported | 10 May 2011 | tx 3+290,000 |
| Paramount Acquisition Corp | 44,150 | reported | 24 Jan 2006 | tx 7+46,150 |
| Hana Biosciences Inc | 40,000 | reported | 24 Feb 2009 | tx 3+120,000 |
| UroGen Pharma Ltd. | 20,000 | reported | 26 Aug 2025 | tx 17+377,723−297,723 |
| SRKP 4 INC | 0 | reported | 03 Jul 2009 | tx 48+681,238−1,414,552 |
| Kite Pharma, Inc. | 0 | reported | 03 Oct 2017 | tx 34+2,118,165−7,615,592 |
| Kronos Bio, Inc. | 0 | reported | 20 Jun 2025 | tx 20+2,861,652−5,923,700 |
7 purchases reported after at least 12 months of silence — most recent on 16 May 2024.
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 02 Feb 2026 | GRANT_AWARD | Allogene Therapeutics, Inc. | 929,913 | 0.00 USD | deriv |
| 02 Feb 2026 | GRANT_AWARD | Allogene Therapeutics, Inc. | 263,033 | 0.00 USD | deriv |
| 26 Aug 2025 | GRANT_AWARD | UroGen Pharma Ltd. | 20,000 | 0.00 USD | deriv |
| 20 Jun 2025 | TENDER | Kronos Bio, Inc. | 679,575 | 0.57 USD | |
| 20 Jun 2025 | TENDER | Kronos Bio, Inc. | 2,765,314 | 0.57 USD | |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 20 Jun 2025 | OTHER | Kronos Bio, Inc. | 20,600 | 0.00 USD | deriv |
| 24 Jan 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 369,957 | 0.00 USD | |
| 24 Jan 2025 | GRANT_AWARD | Allogene Therapeutics, Inc. | 1,307,927 | 0.00 USD | deriv |
| 06 Aug 2024 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 25 Jun 2024 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 12 Jun 2024 | EXERCISE | Ginkgo Bioworks Holdings, Inc. | 105,263 | — | |
| 13 Jun 2024 | GRANT_AWARD | Ginkgo Bioworks Holdings, Inc. | 571,428 | 0.00 USD | deriv |
| 12 Jun 2024 | EXERCISE | Ginkgo Bioworks Holdings, Inc. | 105,263 | — | deriv |
| 13 Jun 2024 | GRANT_AWARD | Ginkgo Bioworks Holdings, Inc. | 432,900 | 0.00 USD | deriv |
| 16 May 2024 | PURCHASE | Allogene Therapeutics, Inc. | 1,724,137 | 2.90 USD | first after silence |
| 16 May 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 344,828 | 2.90 USD | |
| 25 Jan 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 211,973 | 0.00 USD | |
| 25 Jan 2024 | GRANT_AWARD | Allogene Therapeutics, Inc. | 749,398 | 0.00 USD | deriv |
| 07 Sept 2023 | GRANT_AWARD | UroGen Pharma Ltd. | 10,000 | 0.00 USD | deriv |
| 22 Jun 2023 | GRANT_AWARD | Kronos Bio, Inc. | 34,000 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Ginkgo Bioworks Holdings, Inc. | 139,860 | 0.00 USD | deriv |
| 16 Jun 2023 | GRANT_AWARD | Ginkgo Bioworks Holdings, Inc. | 105,263 | 0.00 USD | deriv |